Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kiniksa Pharmaceuticals International, Plc

Clinical trials sponsored by Kiniksa Pharmaceuticals International, Plc, explained in plain language.

Kiniksa Pharmaceuticals International, PLC KNSA NASDAQ

Biopharmaceutical company focused on inflammatory and autoimmune diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1

500 patients join study to unravel recurrent heart inflammation

Knowledge-focused Ongoing

This study follows 500 children and adults with recurrent pericarditis (repeated inflammation of the heart lining) to better understand the disease. Researchers will track which treatments patients use, how the disease affects quality of life, and the economic costs. The goal is …

Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Knowledge-focused

Last updated Jun 27, 2026 09:06 UTC